This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 Jun;19(6):710-1.

doi: 10.1111/j.1525-1497.2004.40402.x.

The place for ACE inhibitors

PMID: 15209612
PMCID: PMC1492388
DOI: 10.1111/j.1525-1497.2004.40402.x

Editorial

The place for ACE inhibitors

Brent G Petty. J Gen Intern Med. 2004 Jun.

. 2004 Jun;19(6):710-1.

doi: 10.1111/j.1525-1497.2004.40402.x.

Author

PMID: 15209612
PMCID: PMC1492388
DOI: 10.1111/j.1525-1497.2004.40402.x

No abstract available

PubMed Disclaimer

Comment on

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.
Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Rosen AB, et al. J Gen Intern Med. 2004 Jun;19(6):669-75. doi: 10.1111/j.1525-1497.2004.30264.x. J Gen Intern Med. 2004. PMID: 15209606 Free PMC article.
Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community.
Rochon PA, Sykora K, Bronskill SE, Mamdani M, Anderson GM, Gurwitz JH, Gill S, Tu JV, Laupacis A. Rochon PA, et al. J Gen Intern Med. 2004 Jun;19(6):676-83. doi: 10.1111/j.1525-1497.2004.30328.x. J Gen Intern Med. 2004. PMID: 15209607 Free PMC article.
Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough.
Morimoto T, Gandhi TK, Fiskio JM, Seger AC, So JW, Cook EF, Fukui T, Bates DW. Morimoto T, et al. J Gen Intern Med. 2004 Jun;19(6):684-91. doi: 10.1111/j.1525-1497.2004.30016.x. J Gen Intern Med. 2004. PMID: 15209608 Free PMC article.

Similar articles

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.
Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Rosen AB, et al. J Gen Intern Med. 2004 Jun;19(6):669-75. doi: 10.1111/j.1525-1497.2004.30264.x. J Gen Intern Med. 2004. PMID: 15209606 Free PMC article.
Microalbuminuria in diabetes mellitus.
Tobe SW, McFarlane PA, Naimark DM. Tobe SW, et al. CMAJ. 2002 Sep 3;167(5):499-503. CMAJ. 2002. PMID: 12240818 Free PMC article. Review. No abstract available.
ACE inhibitors as a shield against diabetic nephropathy.
Materson BJ. Materson BJ. Arch Intern Med. 1996 Feb 12;156(3):239-40. Arch Intern Med. 1996. PMID: 8572832 No abstract available.
[Angiotensin-converting enzyme inhibitors. Principles and rules of use].
Eicher JC, Wolf JE. Eicher JC, et al. Rev Prat. 1998 Apr 1;48(7):771-6. Rev Prat. 1998. PMID: 11767373 Review. French. No abstract available.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Granger CB, et al. Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5. Lancet. 2003. PMID: 13678870 Clinical Trial.

See all similar articles

Cited by

Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure.
Sun S, Kee HJ, Ryu Y, Choi SY, Kim GR, Kim HS, Kee SJ, Jeong MH. Sun S, et al. Sci Rep. 2019 Feb 28;9(1):3018. doi: 10.1038/s41598-019-39423-8. Sci Rep. 2019. PMID: 30816171 Free PMC article.

References

1. Rochon PA, Sykora K, Bronskill SE, et al. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community. J Gen Intern Med. 2004;19 676. 73. - PMC - PubMed
1. Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004;19:669–75. - PMC - PubMed
1. Morimoto T, Gandhi TK, Fiskio JM, et al. Development and validation of a clinical prediction rule for angiotensin-coverting enzyme inhibitor-induced cough. J Gen Intern Med. 2004;19:684–91. - PMC - PubMed
1. Newman TB, Browner WS, Hulley SB, et al. Designing Clinical Research. Philadelphia, Pa: Lippincott Williams & Williams; 2001. Enhancing causal inference in observational studies; pp. 125–38. . In:
1. Mathiesen ER, Hommel E, Giese J, Parving HH, et al. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991;303:81–7. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal